Pharmaceutical

Filter

Current filters:

None

Popular Filters

6720 to 6744 of 7169 results

Halo Thera lead candidate for Duchenne ready for the clinic

20-03-2012

Privately-held US clinical stage biopharma firm Halo Therapeutic says that an independent review of its…

BiotechnologyHalo TherapeuticshalofuginonePharmaceuticalRare diseasesResearch

EuroHYP gets EU grant award for stroke research

20-03-2012

UK-based Proteome Sciences this week reported that Euro-HYP-1, a consortium of leading academic, clinical…

EuropeFinancialNeurologicalPharmaceuticalProteome SciencesResearch

Astra Zeneca abandons TC-5214 regulatory filing as Ph III fails

20-03-2012

In what is another pipeline disappointment for the company, Anglo-Swedish drug major AstraZeneca (LSE:…

AstraZenecaNeurologicalPharmaceuticalRegulationResearchTargacept

Merck & Co drops development of oral vernakalant

20-03-2012

ug giant Merck & Co (NYSE: MRK) has discontinued further development of the oral formulation of vernakalant,…

BrinavessCardio-vascularCardiome PharmaFinancialMerck & CoPharmaceuticalResearchvernakalant

Positive update on Ampio oral eye drug Optina

20-03-2012

Colorado, USA-based biopharma firm Ampio Pharmaceuticals,(Nasdaq: AMPE) yesterday announced that it completed…

Ampio PharmaceuticalsDanazolDiabetesOphthalmicsOptinaPharmaceuticalResearch

US health reform helps Medicare recipients save over $3.2 billion

20-03-2012

As the second anniversary of the US Affordable Care Act approaches, new data shows that more than 5.1…

HealthcareNorth AmericaPharmaceuticalPricing

New Zealand approves Effient listing for clopidogrel-allergic patients

19-03-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, has announced reaching agreement with US…

Asia-PacificCardio-vascularEffientEli LillyPharmaceuticalPricingRegulation

Synergy Health buys only Swiss gamma and X-ray irradiation facility

19-03-2012

UK-based Synergy Health (LSE: SYR), a provider of outsourced sterilization services to the medical device…

Leoni StuderMergers & AcquisitionsPharmaceuticalSynergy Health

Women Rxed more medicines than men, but take less, US study finds

19-03-2012

There is a wide gender divide when it comes to how men and women in the USA are prescribed and adhere…

Cardio-vascularDiabetesHealthcareNorth AmericaPharmaceutical

UCB links with Oxford University for research

19-03-2012

he UK subsidiary of Belgian drugmaker UCB (Euronext Brussels: UCB) said yesterday that it has agreed…

PharmaceuticalResearchUCB

MSF urges more compulsory drug licensing in India

19-03-2012

In the wake of India granting its first compulsory drug license - to local firm Natco Pharma for a genric…

Asia-PacificGenericsPatentsPharmaceutical

Flamel Tech acquires US firm Eclat Pharma; reports loss

19-03-2012

Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

EMA backs Protelos and Osseor, but with warnings

19-03-2012

The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has finalized a review…

Anti-Arthritics/RheumaticsEuropeOsseorPharmaceuticalProtelosRegulationServier

Grifols acquires 51% stake in Araclon Biotech

19-03-2012

Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

Takeda and Pronova highlight TAK-085 Japanese Ph III trial results

19-03-2012

Japanese drug major Takeda Pharmaceutical (TYO: 4502) and Norway-based lipid therapies specialist Pronova…

Cardio-vascularPharmaceuticalPronova BioPharmaResearchTakeda Pharmaceuticals

Sanofi expands in biosurgery, buying Pluromed

18-03-2012

French drug major Sanofi (Euronext: SAN) said on Friday that it is to acquire Pluromed, a USA-based medical…

Mergers & AcquisitionsPharmaceuticalPluromedSanofi

Paion now moving in new direction, analysts note

18-03-2012

German drug developer Paion AG (FSE: PA8) is moving beyond the bat saliva-derived stroke project desmoteplase,…

LicensingNeurologicalPaionPharmaceuticalremimazolamResearch

Shire to acquire FerroKin BioSciences; drops Replagal BLA

16-03-2012

Ireland-headquartered Shire (LSE: SHP) said yesterday that it has signed an agreement to acquire privately-held…

FerroKin BioSciencesMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalRare diseasesRegulationReplagalShire

Novartis unit buys rights to ThromboGenics eye drug

16-03-2012

Belgian biopharma company ThromboGenics (Euronext Brussels: THR) revealed this morning that it has entered…

AlconBiotechnologyLicensingNovartisocriplasminOphthalmicsPharmaceuticalThromboGenics

Esbriet offers additional benefit, says German G-BA

16-03-2012

USA-based InterMune (Nasdaq: ITMN) says that the German Federal Joint Committee (G-BA) has announced…

EsbrietEuropeInterMunePharmaceuticalPricingRegulationRespiratory and Pulmonary

Positive NICE news for Gilenya for MS and Incivo for hep C

16-03-2012

There was good news from the UK drugs watchdog the Institute for Health and Clinical Excellence (NICE)…

Anti-viralsEuropeGilenyaIncivoJanssen-CilagJohnson & JohnsonNeurologicalNovartisPharmaceuticalPricingRegulation

6720 to 6744 of 7169 results

Back to top